[1]
|
Loe, H. and Silness, J. (1963) Periodontal disease in Pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica, 21, 533-551.
doi:10.3109/00016356309011240
|
[2]
|
Raber-Durlacher, J.E., Leene, W., Palmer-Bouva, C.C., et al. (1993) Experimental gingivitis during pregnancy and post-partum: Immunohistochemical aspects. Journal of Periodontology, 64, 211-218.
doi:10.1902/jop.1993.64.3.211
|
[3]
|
Socransky, S.S., Haffajee, A.D., Cugini, M.A., et al. (1998) Complexes in subgingival plaque. Journal of Clinical Periodontology, 25, 134-144.
doi:10.1111/j.1600-051X.1998.tb02419.x
|
[4]
|
Ihara, H., Miura, T., Kato, T., et al. (2003) Detection of Campylobacter rectus in periodontitis sites by monoclonal antibodies. Journal of Periodontal Research, 38, 64-72. doi:10.1034/j.1600-0765.2003.01627.x
|
[5]
|
Darveau, R.P., Tanner, A. and Page, R.C. (1997) The microbial challenge in periodontitis. Journal of Periodontology, 14, 12-32.
doi:10.1111/j.1600-0757.1997.tb00190.x
|
[6]
|
Dzink, J.L., Tanner, A.G.R., Haffajee, A.D., et al. (1995) Gram-negative species associated with active destructive periodontal lesions. Journal of Clinical Periodontology, 12, 648-659. doi:10.1111/j.1600-051X.1985.tb00936.x
|
[7]
|
Marsh, P.D. (1995) Microbial ecology of dental plaque and its significance in health and disease. Advances in Dental Research, 8, 263-271.
|
[8]
|
Lindhe, J., Karring, T. and Lang, N.P. (1999) Anatomy of the parodontium. Clinical parodontology and implantology. Quintessenz, Berlin, Chicago, London, Paris, Tokio, Barcelona, Moskau, Prag, Sao Paulo, Sofia, Warschau.
|
[9]
|
Sheikhi, M., Gustafsson, A. and Jarstrand, C. (2000) Cytokine, élastase and oxygene radical release by Fusobacteium nucleatum—activated leucocytes: A possible pathogenic factor in periodontitis. Journal of Clinical Periodontology, 27, 756-762.
doi:10.1034/j.1600-051x.2000.027010758.x
|
[10]
|
Seymour, G.J. (1991) Importance to the host response in the peridontum. Journal of Clinical Periodontology, 18, 421-426. doi:10.1111/j.1600-051X.1991.tb02310.x
|
[11]
|
Witko-Sarsat, V., Rieu, P., Descamps-Latscha, B., et al. (2000) Neutrophils: Molecules, functions and pathophysiological aspects. Laboratory Investigation, 80, 617-653. doi:10.1038/labinvest.3780067
|
[12]
|
Follin, P., Wyman, M.P., Dewald, B., et al. (1991) Human neutrophil migration into skin chamber is associated with production of NAP-1/IL-8 and Ca5. European Journal of Haematology, 47, 71-76.
doi:10.1111/j.1600-0609.1991.tb00564.x
|
[13]
|
Heasman, P.A., Collins, J.G. and Offenbacher, S. (1993) Changes in cervicular fluid levels of interleukin-1 beta, leucotriene B4, prostaglandin E2, thromboxane B2 and tumor necrosis factor alpha in experimental gingivitis in humans. Journal of Periodontal Research, 28, 241-247. doi:10.1111/j.1600-0765.1993.tb02090.x
|
[14]
|
Dewhirst, F.E., Moss, D.E. and Offenbacher, S. (1983) Levels of prostaglandin E2, thromboxane, and prostacyclin in periodontal tissues. Journal of Periodontal Research, 18, 156-163. doi:10.1111/j.1600-0765.1983.tb00348.x
|
[15]
|
Dahan, M., Nawrocki, B., Elkaim, R., et al. (2001) Expression of matrix metalloproteinases in healthy and diseased gingiva. Journal of Clinical Periodontology, 28, 128-136. doi:10.1034/j.1600-051x.2001.028002128.x
|
[16]
|
Heath, J.K., Gowen, M., Meikle, M.C., et al. (1982) Human gingival tissues in culture synthesize three metalloproteinases and a metalloproteinase inhibitor. Journal of Periodontal Research, 17, 183-190.
doi:10.1111/j.1600-0765.1982.tb01143.x
|
[17]
|
Stewart, M. (1972) Noni: The lore of the Hawaiian medicinal plants. Bulletin of the Pacific Tropical Garden, 2, 37-39.
|
[18]
|
Parsons, C. (1981) Sickness experience and language: Aspects of Tongan and western accounting. Ph.D. Thesis, University of Waikato, Hamilton.
|
[19]
|
Dittmar, A. (1993) Morinda citrifolia L. use in indigenous Samoan medicine. Journal of Herbs, spices and Medicinal Plants, 1, 77-92. doi:10.1300/J044v01n03_08
|
[20]
|
Singh, Y.N., Ikahihifo, T., Panuve, M., et al. (1984) Folk medicine in Tonga. A study on the use of herbal medicines for obstetric and gynaecological conditions and disorders. Journal of Ethnopharmacology, 12, 305-329. doi:10.1016/0378-8741(84)90060-6
|
[21]
|
Bancree, S. (2006) An extract of Morinda citrifolia L. interferes with the serum-induced formation of filamenttous structures in Candida albicans and inhibits germination of Aspergillus nidulans. The American Journal of Chinese Medicine, 34, 503-509.
doi:10.1142/S0192415X0600403X
|
[22]
|
Locher, C.P., Burch, M.T., Mower, H.F., et al. (1995) Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. Journal of Ethnopharmacology, 49, 23-32.
doi:10.1016/0378-8741(95)01299-0
|
[23]
|
Leach, A.J. (1988) Antibacterial activity of some medicinal plants of Papua New Guinea. Science in New Guinea, 14, 1-7.
|
[24]
|
McKoy, M.L.G., Thomas, E.A. and Simon O.R. (2002) Preliminary investigation of the anti-inflammatory properties of an aqueous extract from Morinda citrifolia L. (noni). Pharmacological Society, 45, 76-78.
|
[25]
|
Kim, H.J., Jang, S.I., Kim, Y.J., et al. (2004) Scopoletin suppresses pro-inflammatory cytokines and PGE2 from LPS-stimulated cell line, RAW 264.7 cells. Fitoterapia, 75, 261-266. doi:10.1016/j.fitote.2003.12.021
|
[26]
|
Hirazumi, A., Furusawa, E., Chou, S.C., et al. (1996) Immunomodulation contributes to the anticancer activity of Morinda citrifolia L. (noni) fruit juice. Proceedings of the Western Pharmacology Society, 39, 7-9.
|
[27]
|
Hokama, Y. (1993) The effect of noni fruit extract (Morinda citrifolia L., Indian mulberry) on thymocytes of BALB/c mouse. The FASEB Journal, 7, A866.
|
[28]
|
Basar, S., Uhlenhut, K., Westendorf, J., et al. (2009) Analgesic and anti-inflammatory activity of Morinda citrifolia L. (noni) fruit. Phytotherapy Research, 24, 38-42. doi:10.1002/ptr.2863
|
[29]
|
Saxer, U.P. and Mühlemann, H.P. (1975) Motivation and education. SSO Schweiz Monatsschr Zahnheilkd, 85, 905-919.
|
[30]
|
Xu, J., Mc Sloy, A.C., Anderson, B.K., et al. (2006) Tahitian Noni equine essentialsTM: A novel anti-inflammatory and a COX-2 inhibitor which regulates LPS-induced inflammatory mediator expression in equine neonatal monocytes. Journal of Veterinary Internal Medicine, 20, 756.
|